Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SABATO: Early Oral Switch in S. Aureus Bloodstream Infection
NCT01792804Phase 3Completed
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Dec 2013
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole, clindamycin, linezolid in Staphylococcus aureus bloodstream infection (SABSI), sponsored by Heinrich Heine University Düsseldorf. Started Dec 2013; status: completed.
02
Drugs
trimethoprim + sulfamethoxazoleclindamycinlinezolid
03
Conditions
Staphylococcus aureus bloodstream infection (SABSI)
Beyond the preview
Go deeper on NCT01792804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01792804.